#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Niemann-Pick disease Lymphangioma Giant cell tumour of tendon sheath Chronic myelomonocytic leukaemia Metabolic disorder Cervix carcinoma Philadelphia positive acute lymphocytic leukaemia Anti-myelin-associated glycoprotein antibodies positive Fibrosarcoma metastatic Myxofibrosarcoma Malignant peritoneal neoplasm Sjogren's syndrome Anal squamous cell carcinoma Erythema Ehlers-Danlos syndrome More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive Glycogen storage disease type V Lennox-Gastaut syndrome – Basic Information Chondrosarcoma metastatic Familial haemophagocytic lymphohistiocytosis – Diagnostics Hypereosinophilic syndrome Congenital nephrogenic diabetes insipidus – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Lymphangiosarcoma – Diagnostics Glycogen storage disease type II More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Laronidase Oxitriptan Nitrogen Propranolol Hydrochloride Tolcapone Tub-040 Isavuconazonium Sulfate Methylphenidate Hydrochloride Floxuridine Evencaleucel Quizartinib Dihydrochloride Fenebrutinib Flutamide Selpercatinib Cannabis Sativa Flower Gliclazide Zinc Oxide Pegargiminase Myrrh VORMATRIGINE More therapies…

    Learn about Your Condition

    Optic ischaemic neuropathy Endometrial cancer stage IV Deafness neurosensory Amyotrophic lateral sclerosis Rectal cancer Cardiac ventricular thrombosis Colitis Major depression Mucosal inflammation Malignant oligodendroglioma Dementia Alzheimer's type Pharyngeal cancer stage II Renal cell carcinoma Nephropathy Crohn's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Oseltamivir and Drug Combination for Patients with Pneumonia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Oseltamivir
    • Baloxavir Marboxil
    • Hydrocortisone Sodium Succinate
    Belgium Estonia France Italy The Netherlands Portugal +3

  • Study on the Effects of ZN-c3 for Patients with High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Azenosertib
    • Betamethasone Sodium Phosphate Ph. Eur
    • Granisetron
    Belgium France Italy Poland Spain

  • Study on Adding Diclofenac to PD-1 Inhibitor Therapy for Patients with Metastatic Melanoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Metastatic malignant melanoma
    Investigated Drugs:
    • Pantoprazole
    • Diclofenac Sodium
    • Nivolumab
    Germany

  • Study of Elafibranor for Adults with Primary Biliary Cholangitis

    Recruiting

    3 1
    Investigated Diseases:
    • Primary biliary cholangitis
    Investigated Drugs:
    • Elafibranor
    Belgium Bulgaria Czechia Denmark France Greece +8

  • Study on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer’s-Related Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study on the Effectiveness of Doxorubicin, Ifosfamide, and Dacarbazine in High-Risk Patients with Resectable Soft-Tissue Sarcoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Dacarbazine
    • Ifosfamide
    • Doxorubicin Hydrochloride
    France
Previous Page
1 … 432 433 434 435 436 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!